CervoMed (CRVO) Prepaid Assets (2010 - 2026)
CervoMed (CRVO) posted Prepaid Assets of $1.7 million for Q1 2026, up 33.81% sequentially from $1.3 million in Q4 2025, and little changed YoY from $1.7 million in Q1 2025.
CervoMed (CRVO) Prepaid Assets (2010 - 2026) Analysis & Trends
CervoMed has reported Prepaid Assets for 17 years, with the latest figure at $1.7 million in Q1 2026.
- Quarterly Prepaid Assets changed 0.49% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (changed 0.49% YoY) and the FY2025 annual result came in at $1.3 million, down 33.5% from the prior year.
- Prepaid Assets climbed to $1.7 million in Q1 2026 per CRVO's latest filing, from $1.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.2 million in Q2 2024 and troughed at $64127.0 in Q4 2022.
- A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets sank 87.43% in 2022, then soared 1859.39% in 2023.
- Over 5 years, Prepaid Assets stood at $64127.0 in 2022, then jumped by 1859.39% to $1.3 million in 2023, then jumped by 51.64% to $1.9 million in 2024, then plunged by 33.5% to $1.3 million in 2025, then jumped by 33.81% to $1.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.7 million, $1.3 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 733,718.00 |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 695,070.00 |
| Mar 31, 2023 | 767,530.00 |
| Dec 31, 2022 | 64,127.00 |
| Sep 30, 2022 | 464,884.00 |
| Jun 30, 2022 | 643,618.00 |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 510,015.00 |
| Sep 30, 2021 | 380,097.00 |